Co-Diagnostics Inc (NASDAQ:CODX)
| 14.30 Delayed Data As of Sep 25 |  +0.52 / +3.77%Today’s Change | 0.85 Today|||52-Week Range 30.99 | +1,497.41% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $402.1M |
Company Description
Co-Diagnostics, Inc. engages in the development, manufacture, and marketing of diagnostics technology. It offers design services, vector control, equipment, diagnostic, and research solutions. The company was founded by Brent C. Satterfield and Dwight H. Egan on April 18, 2013 and is headquartered in Salt Lake City, UT.
Contact Information
Co-Diagnostics, Inc. 2401 South Foothill Drive Salt Lake City Utah 84109 |
Employees
Shareholders
| Individual stakeholders | 8.43% |
| Other institutional | 12.51% |
| Mutual fund holders | 11.50% |
Top Executives
| Dwight Howard Egan | Chairman, President & Chief Executive Officer |
| Reed L. Benson | Chief Financial Officer & Secretary |
| Brent C. Satterfield | Chief Technology Officer & Chief Science Officer |
